-transparent.png){kind=logo}
The article discusses the results of the examination of 40 patients with symptomatic renal hypertension (in 15 of whom arterial hypertension followed a malignant course) and 19 patients with IIB-IIIA stages of hypertensive disease (6 of whom had the malignant form). Marked activation of the renin-angiotensin system along with reduced renal blood flow was found in patients with symptomatic renal hypertension. Despite the reduced renal blood flow, patients with the malignant form of hypertensive disease had diminished activity and secretion of renin as well as a considerably increased prostaglandin F2 alpha content and reduced sodium content in the plasma of renal venous and, particularly in the plasma of aortic blood.
A I Kutsenko, and
V M Shpil'kin, and
P P Boiadzhan, and
Iu V Levitskaia, and
L S Shapkina
January 1985,
Advances in prostaglandin, thromboxane, and leukotriene research,
A I Kutsenko, and
V M Shpil'kin, and
P P Boiadzhan, and
Iu V Levitskaia, and
L S Shapkina
June 1985,
Vrachebnoe delo,
A I Kutsenko, and
V M Shpil'kin, and
P P Boiadzhan, and
Iu V Levitskaia, and
L S Shapkina
January 1987,
Agents and actions. Supplements,
A I Kutsenko, and
V M Shpil'kin, and
P P Boiadzhan, and
Iu V Levitskaia, and
L S Shapkina
July 1977,
Mayo Clinic proceedings,
A I Kutsenko, and
V M Shpil'kin, and
P P Boiadzhan, and
Iu V Levitskaia, and
L S Shapkina
January 1977,
Medicina,
A I Kutsenko, and
V M Shpil'kin, and
P P Boiadzhan, and
Iu V Levitskaia, and
L S Shapkina
January 1989,
Revista espanola de fisiologia,
A I Kutsenko, and
V M Shpil'kin, and
P P Boiadzhan, and
Iu V Levitskaia, and
L S Shapkina
August 2007,
American journal of hypertension,
A I Kutsenko, and
V M Shpil'kin, and
P P Boiadzhan, and
Iu V Levitskaia, and
L S Shapkina
May 1977,
Fortschritte der Medizin,
A I Kutsenko, and
V M Shpil'kin, and
P P Boiadzhan, and
Iu V Levitskaia, and
L S Shapkina
February 1980,
Polski tygodnik lekarski (Warsaw, Poland : 1960),
A I Kutsenko, and
V M Shpil'kin, and
P P Boiadzhan, and
Iu V Levitskaia, and
L S Shapkina
January 1981,
Pharmacology & therapeutics,
